It may sound obvious that pharmaceutical companies operate according to the unique set of regulations, healthcare environments, market conditions, and cultures of the regions in which they operate, but what do such differences reveal about the industry as a whole?
In this episode, Sabine Dettwiler, Managing Director, Commercial Advisory Group at Syneos Health Consulting, shares some learnings from her experience in the U.S., Asia, and Europe – comparing and contrasting the pharmaceutical landscape across all three, including the challenges of clinical trial diversity, cultural barriers, and the differing values and priorities of healthcare providers.
For a deeper dive into our perspective on trends in the oncology landscape in China, listen to this podcast episode.
If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you’ll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision making and investment. You can find it all at insightshub.health.
Like what you’re hearing? Be sure to rate and review us!
We want to hear from you! If there’s a topic you’d like us to cover on a future episode, contact us at [email protected].